Manufacturers of medical devices and in-vitro diagnostic medical devices must report, in advance, certain situations involving the discontinuation of marketing or a temporary supply disruption of medical devices and in-vitro diagnostic medical devices. A form common to all Member States allows them to fulfill this new obligation.